Navy: No Gunfire At San Diego Medical Center

If President Trump has been clear on one thing, it's that globalized trade is a raw deal for American workers. Of course, most mainstream economists and commentators do not agree, to put it mildly. They see globalized trade as a win-win for everyone, and Trump's "America First" agenda as myopic and destructive. But our protectionist in chief is getting at least a little sympathy from one unlikely group: progressive economists. That sympathy is complicated, and it doesn't often translate into support for Trump's specific policies.

Why is President Trump so enamored with Vladimir Putin? It's impossible to miss Trump's regular warm remarks about the Russian leader, and his weirdly deferential policy suggestions — like letting Russia back in the G-7. Clearly, either Trump simply likes Putin and his style of politics, or Putin has some kind of secret leverage on Trump, or both. Whatever the reason, this is very bad for America and the world.

Politics makes strange bedfellows, and no public menage in our time is odder than the one in which liberals have united with far-right online LARPers in pretending that both President Trump and Russia's Vladimir Putin are ferocious reactionaries. There is nothing reactionary or particularly supervillainous about Putin or his regime. Far from being a kind of theocratic neo-tsar who seeks to revive the glorious dream of the Rus' in the hearts of his post-Soviet countrymen and bring the decadent neoliberal West to heel, he is actually a cheap grifter, the head of an international mafia of oilmen and mineral tycoons who starve their fellow citizens in order to purchase luxury condos in the various major cities of Western Europe.

Each week, we spotlight a cool innovation recommended by some of the industry's top tech writers. This week's pick is an AI that can predict patients' outcomes. "Google is training machines to predict when a patient will die," said Mark Bergen at Bloomberg. Medical engineers with the company's health research unit — sometimes referred to as Medical Brain — have created an AI algorithm that can "forecast a host of patient outcomes, including how long people may stay in hospitals, their odds of readmission, and chances they will soon die." Google's tool can "sift through data previously out of reach," such as doctors' notes in PDFs or scrawled on old charts, and produce predictions "far faster and more accurately than existing techniques." (Courtesy image) Health-care providers "have been trying for years to better use stockpiles of electronic health records and other patient data" to inform treatments and decisions.

Almost everyone wears glasses at some point in their lives. In developed countries, the rule of thumb is that around 70 percent of adults need corrective lenses to see well. And over the last generation, just two companies have risen above all the rest to dominate the industry. The lenses in my glasses — and yours too, most likely — were made by Essilor, a French multinational that controls almost half of the world's prescription lens business and has acquired more than 250 other companies in the past 20 years. There is a good chance, meanwhile, that your frames were made by Luxottica, an Italian company with an unparalleled combination of factories, designer labels, and retail outlets.

A mob of angry villagers has killed hundreds of protected crocodiles in Indonesia’s far-eastern province of West Papua in what appears to be a retaliatory attack after a person was killed by one of the reptiles. Police and officials say they were unable to stop the massacre and may press charges against attackers, the BBC reports.